ログイン

Routes of Administration

Routes of Administration
79問 • 1年前
  • ユーザ名非公開
  • 通報

    問題一覧

  • 1

    Also known as presystemic metabolism

    First Pass Effect

  • 2

    High First Pass Effect: _____ Bioavailability

    Decreased

  • 3

    Must be swallowed and has COMPLETE first-pass effect

    Oral Route

  • 4

    Provides systemic effect

    Oral Route

  • 5

    Drug is inserted in the rectum

    Rectal Route

  • 6

    May give local or systemic effect Buccal route

    Rectal Route

  • 7

    Can partially bypass the first-pass effect

    Rectal Route

  • 8

    Placed BETWEEN gums and inner lining of the cheek

    Buccal Route

  • 9

    Placed under the tongue

    Sublingual route

  • 10

    Available dosage form for Nitroglycerin

    Sublingual route

  • 11

    ENTERAL routes that CAN COMPLETELY BYPASS FIRST PASS EFFECT

    Sublingual route, Buccal Route

  • 12

    Emergency route

    IV Push

  • 13

    Non Emergency Route (More that 30 minutes)

    IV Infusion

  • 14

    Both emergency and non emergency route (1-30 minutes)

    IV Bolus

  • 15

    Which is slower among the two

    Subcutaneous

  • 16

    Injected into the muscle

    Intramuscular

  • 17

    90 degrees angle

    Intramuscular

  • 18

    Injected into the veins

    Intravenous

  • 19

    25 degrees angle

    Intravenous

  • 20

    100% Bioavailability or Absolute availability

    Intravenous

  • 21

    TB testing route

    Intradermal

  • 22

    Allergy testing route

    Intradermal

  • 23

    Injected into the dermis

    Intradermal

  • 24

    Injected into the corium

    Intradermal

  • 25

    10-15 degree angle

    Intradermal

  • 26

    Carbonic Anhydrase Inhibitor that is DIURETIC also a treatment for GLAUCOMA

    Acetazolamide

  • 27

    Injected under the skin

    Subcutaneous

  • 28

    25 degrees angle

    Subcutaneous

  • 29

    Drug given via subcutaneous route

    Heparin

  • 30

    Drug given via subcutaneous route

    Insulin

  • 31

    Injected into the spinal canal

    Intrathecal

  • 32

    Injected into the subarachnoid spaces

    Intrathecal

  • 33

    20 degrees angle

    Intrathecal

  • 34

    Methotrexate

    Intrathecal

  • 35

    Cytarabine

    Intrathecal

  • 36

    Hydrocortisone

    Intrathecal

  • 37

    Morphine

    Intrathecal

  • 38

    Morphine

    Intrathecal

  • 39

    Vinca alkaloids such as Vincristine when given intrathecally:

    Fatal

  • 40

    Injected inside the joint cavity

    Intra-articular

  • 41

    45 degree angle

    Intra-articular

  • 42

    Route of Glucocorticoids for Osteoarthritis

    Intra-articular

  • 43

    Route of Hyarulonic acid for Osteoarthritis

    Intra-articular

  • 44

    Identify the ROA used in the graph This is given via IV

    IV Bolus

  • 45

    Identify the route of administration used in the graph Given via IV

    IV Infusion

  • 46

    Identify the route of administration used in the graph Given via orally

    Extended release

  • 47

    Identify the route of administration used in the graph Given via orally

    Immediate release

  • 48

    Quick release when taken orally

    Immediate release

  • 49

    Steady state drug concentration

    Extended release

  • 50

    Allows precise control of PLASMA drug concentration

    IV Infusion

  • 51

    Rapid injection of medication needed to achieve immediate effect

    IV Bolus

  • 52

    Peak concentration is obtained Immediately after the dose is given

    IV Bolus

  • 53

    What is collor green in the graph

    Extended released

  • 54

    What is collor red in the graph

    Immediate released

  • 55

    What is collor blue in the graph

    Delayed released

  • 56

    Drug A is extended release and Drug B is given delayed release but has the same brand

    Pharmaceutical Alternative

  • 57

    What ROA are the zigzags, red and black

    Multiple IV Bolus

  • 58

    What ROA is the curve line color black?

    IV Infusion

  • 59

    Cmax

    Peak

  • 60

    Cmin

    Trough

  • 61

    Time the trough level needed to reach the MEC

    8

  • 62

    Time the trough level needed to reach the CSS or Concentration of Steady State

    16

  • 63

    What would most likely be the reason for the drug’s increasing plasma concentration towards reaching the therapeutic range?

    Decreasing clearance of the drug thru time

  • 64

    Increasing Plasma Concentration = Increased half life = _______ Drug clearance

    Decreasing

  • 65

    Administered at the SITE where the pharmacological response is desired

    Local Route

  • 66

    Have MINIMAL absorption to the SYSTEMIC circulation

    Local Route

  • 67

    Salbutamol for Asthma

    Local Route

  • 68

    Topical steroids for Eczema

    Local Route

  • 69

    ICS drugs for Allrgic rhinitis

    Local Route

  • 70

    The drug administered reaches the blood stream and produce systemic effect

    Systemic Route

  • 71

    Oral Amoxicillin

    Systemic Effect

  • 72

    Intravenous and Intramuscular

    Systemic Effect

  • 73

    Transdermal patch

    Systemic Effect

  • 74

    Rectal

    Both

  • 75

    Bronchodilators

    Local effects

  • 76

    GENERAL anesthesia

    Systemic Effect

  • 77

    Which of the following refers to the form of parenteral administration that involves injecting drugs such as methotrexate to the spinal cord?

    Intrathecal

  • 78

    The peak concentration for an intravenous bolus dose would be obtained ____.

    Immediately after the dose is given

  • 79

    Which are TRUE regarding local effect of drugs? I. Drug is administered at the site where the pharmacological response is desired. II. Drug preparations intended to produce local effects have minimal absorption to the systemic circulation. III. Anti-asthma drugs administered via inhalational route produce local effects.

    I, II and III

  • Module 2 Part 1

    Module 2 Part 1

    ユーザ名非公開 · 100問 · 1年前

    Module 2 Part 1

    Module 2 Part 1

    100問 • 1年前
    ユーザ名非公開

    Module 1

    Module 1

    ユーザ名非公開 · 13問 · 1年前

    Module 1

    Module 1

    13問 • 1年前
    ユーザ名非公開

    Module 2

    Module 2

    ユーザ名非公開 · 100問 · 1年前

    Module 2

    Module 2

    100問 • 1年前
    ユーザ名非公開

    Antibiotics

    Antibiotics

    ユーザ名非公開 · 10問 · 1年前

    Antibiotics

    Antibiotics

    10問 • 1年前
    ユーザ名非公開

    Module 2 Part 2

    Module 2 Part 2

    ユーザ名非公開 · 100問 · 1年前

    Module 2 Part 2

    Module 2 Part 2

    100問 • 1年前
    ユーザ名非公開

    Module 2 (Part 2)

    Module 2 (Part 2)

    ユーザ名非公開 · 100問 · 1年前

    Module 2 (Part 2)

    Module 2 (Part 2)

    100問 • 1年前
    ユーザ名非公開

    Module 2 Part 3

    Module 2 Part 3

    ユーザ名非公開 · 85問 · 1年前

    Module 2 Part 3

    Module 2 Part 3

    85問 • 1年前
    ユーザ名非公開

    Module 4

    Module 4

    ユーザ名非公開 · 100問 · 1年前

    Module 4

    Module 4

    100問 • 1年前
    ユーザ名非公開

    Module 4 Part 2

    Module 4 Part 2

    ユーザ名非公開 · 100問 · 1年前

    Module 4 Part 2

    Module 4 Part 2

    100問 • 1年前
    ユーザ名非公開

    Module 4 Part 3

    Module 4 Part 3

    ユーザ名非公開 · 60問 · 1年前

    Module 4 Part 3

    Module 4 Part 3

    60問 • 1年前
    ユーザ名非公開

    Module 2 (Part 4)

    Module 2 (Part 4)

    ユーザ名非公開 · 68問 · 1年前

    Module 2 (Part 4)

    Module 2 (Part 4)

    68問 • 1年前
    ユーザ名非公開

    Randome Questions

    Randome Questions

    ユーザ名非公開 · 13問 · 1年前

    Randome Questions

    Randome Questions

    13問 • 1年前
    ユーザ名非公開

    1

    1

    ユーザ名非公開 · 100問 · 1年前

    1

    1

    100問 • 1年前
    ユーザ名非公開

    Module 2 (Part 5)

    Module 2 (Part 5)

    ユーザ名非公開 · 100問 · 1年前

    Module 2 (Part 5)

    Module 2 (Part 5)

    100問 • 1年前
    ユーザ名非公開

    2

    2

    ユーザ名非公開 · 100問 · 1年前

    2

    2

    100問 • 1年前
    ユーザ名非公開

    Module 2 (Part 6)

    Module 2 (Part 6)

    ユーザ名非公開 · 68問 · 1年前

    Module 2 (Part 6)

    Module 2 (Part 6)

    68問 • 1年前
    ユーザ名非公開

    Module 4 Part 1

    Module 4 Part 1

    ユーザ名非公開 · 5問 · 1年前

    Module 4 Part 1

    Module 4 Part 1

    5問 • 1年前
    ユーザ名非公開

    BCS

    BCS

    ユーザ名非公開 · 36問 · 1年前

    BCS

    BCS

    36問 • 1年前
    ユーザ名非公開

    Pharmacokinetics

    Pharmacokinetics

    ユーザ名非公開 · 86問 · 1年前

    Pharmacokinetics

    Pharmacokinetics

    86問 • 1年前
    ユーザ名非公開

    Enzyme Inducers and Enzyme Inhibitors

    Enzyme Inducers and Enzyme Inhibitors

    ユーザ名非公開 · 25問 · 1年前

    Enzyme Inducers and Enzyme Inhibitors

    Enzyme Inducers and Enzyme Inhibitors

    25問 • 1年前
    ユーザ名非公開

    Metabolism and Excretion

    Metabolism and Excretion

    ユーザ名非公開 · 31問 · 1年前

    Metabolism and Excretion

    Metabolism and Excretion

    31問 • 1年前
    ユーザ名非公開

    PHARMACODYNAMICS

    PHARMACODYNAMICS

    ユーザ名非公開 · 88問 · 1年前

    PHARMACODYNAMICS

    PHARMACODYNAMICS

    88問 • 1年前
    ユーザ名非公開

    Ramdom

    Ramdom

    ユーザ名非公開 · 6問 · 1年前

    Ramdom

    Ramdom

    6問 • 1年前
    ユーザ名非公開

    A. Parasympathetic (Cholinergic) Drugs

    A. Parasympathetic (Cholinergic) Drugs

    ユーザ名非公開 · 43問 · 1年前

    A. Parasympathetic (Cholinergic) Drugs

    A. Parasympathetic (Cholinergic) Drugs

    43問 • 1年前
    ユーザ名非公開

    3

    3

    ユーザ名非公開 · 100問 · 1年前

    3

    3

    100問 • 1年前
    ユーザ名非公開

    4

    4

    ユーザ名非公開 · 100問 · 1年前

    4

    4

    100問 • 1年前
    ユーザ名非公開

    Module 1

    Module 1

    ユーザ名非公開 · 100問 · 1年前

    Module 1

    Module 1

    100問 • 1年前
    ユーザ名非公開

    Module 1

    Module 1

    ユーザ名非公開 · 100問 · 1年前

    Module 1

    Module 1

    100問 • 1年前
    ユーザ名非公開

    Module 2

    Module 2

    ユーザ名非公開 · 100問 · 1年前

    Module 2

    Module 2

    100問 • 1年前
    ユーザ名非公開

    Module 3

    Module 3

    ユーザ名非公開 · 100問 · 1年前

    Module 3

    Module 3

    100問 • 1年前
    ユーザ名非公開

    Module 2

    Module 2

    ユーザ名非公開 · 100問 · 1年前

    Module 2

    Module 2

    100問 • 1年前
    ユーザ名非公開

    Module 3

    Module 3

    ユーザ名非公開 · 100問 · 1年前

    Module 3

    Module 3

    100問 • 1年前
    ユーザ名非公開

    Module 3 Rationales

    Module 3 Rationales

    ユーザ名非公開 · 100問 · 1年前

    Module 3 Rationales

    Module 3 Rationales

    100問 • 1年前
    ユーザ名非公開

    Terms

    Terms

    ユーザ名非公開 · 19問 · 1年前

    Terms

    Terms

    19問 • 1年前
    ユーザ名非公開

    Module 3 Rationales

    Module 3 Rationales

    ユーザ名非公開 · 29問 · 1年前

    Module 3 Rationales

    Module 3 Rationales

    29問 • 1年前
    ユーザ名非公開

    Excipients

    Excipients

    ユーザ名非公開 · 19問 · 1年前

    Excipients

    Excipients

    19問 • 1年前
    ユーザ名非公開

    Module 4

    Module 4

    ユーザ名非公開 · 100問 · 1年前

    Module 4

    Module 4

    100問 • 1年前
    ユーザ名非公開

    Flavors,Sweeteners, and Colors

    Flavors,Sweeteners, and Colors

    ユーザ名非公開 · 17問 · 1年前

    Flavors,Sweeteners, and Colors

    Flavors,Sweeteners, and Colors

    17問 • 1年前
    ユーザ名非公開

    Module 5

    Module 5

    ユーザ名非公開 · 100問 · 1年前

    Module 5

    Module 5

    100問 • 1年前
    ユーザ名非公開

    Anti Glaucoma

    Anti Glaucoma

    ユーザ名非公開 · 23問 · 1年前

    Anti Glaucoma

    Anti Glaucoma

    23問 • 1年前
    ユーザ名非公開

    B. Parasympathetic (Cholinergic) Blockers — Anti Cholinergic Agents

    B. Parasympathetic (Cholinergic) Blockers — Anti Cholinergic Agents

    ユーザ名非公開 · 20問 · 1年前

    B. Parasympathetic (Cholinergic) Blockers — Anti Cholinergic Agents

    B. Parasympathetic (Cholinergic) Blockers — Anti Cholinergic Agents

    20問 • 1年前
    ユーザ名非公開

    C. Sympathetic (Adrenergic) Drugs

    C. Sympathetic (Adrenergic) Drugs

    ユーザ名非公開 · 80問 · 1年前

    C. Sympathetic (Adrenergic) Drugs

    C. Sympathetic (Adrenergic) Drugs

    80問 • 1年前
    ユーザ名非公開

    D. Sympathetic (Adrenergic) BLOCKERS

    D. Sympathetic (Adrenergic) BLOCKERS

    ユーザ名非公開 · 15問 · 1年前

    D. Sympathetic (Adrenergic) BLOCKERS

    D. Sympathetic (Adrenergic) BLOCKERS

    15問 • 1年前
    ユーザ名非公開

    E. Nicotinic Receptor Blockers

    E. Nicotinic Receptor Blockers

    ユーザ名非公開 · 30問 · 1年前

    E. Nicotinic Receptor Blockers

    E. Nicotinic Receptor Blockers

    30問 • 1年前
    ユーザ名非公開

    F. Central Muscle Relaxants (or Spasmolytic agents)

    F. Central Muscle Relaxants (or Spasmolytic agents)

    ユーザ名非公開 · 19問 · 1年前

    F. Central Muscle Relaxants (or Spasmolytic agents)

    F. Central Muscle Relaxants (or Spasmolytic agents)

    19問 • 1年前
    ユーザ名非公開

    Rationale Quiz 1.0

    Rationale Quiz 1.0

    ユーザ名非公開 · 13問 · 1年前

    Rationale Quiz 1.0

    Rationale Quiz 1.0

    13問 • 1年前
    ユーザ名非公開

    A. Anxiolytic Agents

    A. Anxiolytic Agents

    ユーザ名非公開 · 26問 · 1年前

    A. Anxiolytic Agents

    A. Anxiolytic Agents

    26問 • 1年前
    ユーザ名非公開

    B.1 Drugs for Depression

    B.1 Drugs for Depression

    ユーザ名非公開 · 29問 · 1年前

    B.1 Drugs for Depression

    B.1 Drugs for Depression

    29問 • 1年前
    ユーザ名非公開

    B.2 Drugs for Mania / Bipolar Disorder

    B.2 Drugs for Mania / Bipolar Disorder

    ユーザ名非公開 · 15問 · 1年前

    B.2 Drugs for Mania / Bipolar Disorder

    B.2 Drugs for Mania / Bipolar Disorder

    15問 • 1年前
    ユーザ名非公開

    C. Drugs for Psychoses - Typical and Atypical Antipsychotics

    C. Drugs for Psychoses - Typical and Atypical Antipsychotics

    ユーザ名非公開 · 44問 · 1年前

    C. Drugs for Psychoses - Typical and Atypical Antipsychotics

    C. Drugs for Psychoses - Typical and Atypical Antipsychotics

    44問 • 1年前
    ユーザ名非公開

    D. Drugs for Seizure Disorders

    D. Drugs for Seizure Disorders

    ユーザ名非公開 · 36問 · 1年前

    D. Drugs for Seizure Disorders

    D. Drugs for Seizure Disorders

    36問 • 1年前
    ユーザ名非公開

    E. General Anesthetics

    E. General Anesthetics

    ユーザ名非公開 · 32問 · 1年前

    E. General Anesthetics

    E. General Anesthetics

    32問 • 1年前
    ユーザ名非公開

    G. Anti-Parkinson Drugs

    G. Anti-Parkinson Drugs

    ユーザ名非公開 · 26問 · 1年前

    G. Anti-Parkinson Drugs

    G. Anti-Parkinson Drugs

    26問 • 1年前
    ユーザ名非公開

    H. Drugs for Alzheimer's Disease

    H. Drugs for Alzheimer's Disease

    ユーザ名非公開 · 6問 · 1年前

    H. Drugs for Alzheimer's Disease

    H. Drugs for Alzheimer's Disease

    6問 • 1年前
    ユーザ名非公開

    Rationale Quiz 2

    Rationale Quiz 2

    ユーザ名非公開 · 5問 · 1年前

    Rationale Quiz 2

    Rationale Quiz 2

    5問 • 1年前
    ユーザ名非公開

    1

    1

    ユーザ名非公開 · 100問 · 1年前

    1

    1

    100問 • 1年前
    ユーザ名非公開

    2

    2

    ユーザ名非公開 · 100問 · 1年前

    2

    2

    100問 • 1年前
    ユーザ名非公開

    3

    3

    ユーザ名非公開 · 100問 · 1年前

    3

    3

    100問 • 1年前
    ユーザ名非公開

    4

    4

    ユーザ名非公開 · 100問 · 1年前

    4

    4

    100問 • 1年前
    ユーザ名非公開

    5

    5

    ユーザ名非公開 · 100問 · 1年前

    5

    5

    100問 • 1年前
    ユーザ名非公開

    6

    6

    ユーザ名非公開 · 100問 · 1年前

    6

    6

    100問 • 1年前
    ユーザ名非公開

    1. Diuretics

    1. Diuretics

    ユーザ名非公開 · 34問 · 1年前

    1. Diuretics

    1. Diuretics

    34問 • 1年前
    ユーザ名非公開

    2. Angiotensin Blockers

    2. Angiotensin Blockers

    ユーザ名非公開 · 12問 · 1年前

    2. Angiotensin Blockers

    2. Angiotensin Blockers

    12問 • 1年前
    ユーザ名非公開

    3 and 4. CCBs: Non-dihydropyridines and Vasodilators

    3 and 4. CCBs: Non-dihydropyridines and Vasodilators

    ユーザ名非公開 · 20問 · 1年前

    3 and 4. CCBs: Non-dihydropyridines and Vasodilators

    3 and 4. CCBs: Non-dihydropyridines and Vasodilators

    20問 • 1年前
    ユーザ名非公開

    Module 2

    Module 2

    ユーザ名非公開 · 17問 · 1年前

    Module 2

    Module 2

    17問 • 1年前
    ユーザ名非公開

    Pharmacodynamics

    Pharmacodynamics

    ユーザ名非公開 · 23問 · 1年前

    Pharmacodynamics

    Pharmacodynamics

    23問 • 1年前
    ユーザ名非公開

    Drug Classes

    Drug Classes

    ユーザ名非公開 · 15問 · 1年前

    Drug Classes

    Drug Classes

    15問 • 1年前
    ユーザ名非公開

    MOA

    MOA

    ユーザ名非公開 · 24問 · 1年前

    MOA

    MOA

    24問 • 1年前
    ユーザ名非公開

    5. Sympatholytics

    5. Sympatholytics

    ユーザ名非公開 · 11問 · 1年前

    5. Sympatholytics

    5. Sympatholytics

    11問 • 1年前
    ユーザ名非公開

    B. Drugs for Heart Failure

    B. Drugs for Heart Failure

    ユーザ名非公開 · 6問 · 1年前

    B. Drugs for Heart Failure

    B. Drugs for Heart Failure

    6問 • 1年前
    ユーザ名非公開

    C. Drugs for Arrhythmia

    C. Drugs for Arrhythmia

    ユーザ名非公開 · 36問 · 1年前

    C. Drugs for Arrhythmia

    C. Drugs for Arrhythmia

    36問 • 1年前
    ユーザ名非公開

    D. Drugs for Hyperlipidemia

    D. Drugs for Hyperlipidemia

    ユーザ名非公開 · 11問 · 1年前

    D. Drugs for Hyperlipidemia

    D. Drugs for Hyperlipidemia

    11問 • 1年前
    ユーザ名非公開

    E. Angina Pectoris

    E. Angina Pectoris

    ユーザ名非公開 · 10問 · 1年前

    E. Angina Pectoris

    E. Angina Pectoris

    10問 • 1年前
    ユーザ名非公開

    F. Thrombotic Disorders

    F. Thrombotic Disorders

    ユーザ名非公開 · 50問 · 1年前

    F. Thrombotic Disorders

    F. Thrombotic Disorders

    50問 • 1年前
    ユーザ名非公開

    Antidotes

    Antidotes

    ユーザ名非公開 · 8問 · 1年前

    Antidotes

    Antidotes

    8問 • 1年前
    ユーザ名非公開

    Deficiencies

    Deficiencies

    ユーザ名非公開 · 9問 · 1年前

    Deficiencies

    Deficiencies

    9問 • 1年前
    ユーザ名非公開

    A. Growth Hormones

    A. Growth Hormones

    ユーザ名非公開 · 16問 · 1年前

    A. Growth Hormones

    A. Growth Hormones

    16問 • 1年前
    ユーザ名非公開

    B. Adrenal Steroids

    B. Adrenal Steroids

    ユーザ名非公開 · 30問 · 1年前

    B. Adrenal Steroids

    B. Adrenal Steroids

    30問 • 1年前
    ユーザ名非公開

    C. GnRH, FSH & LH & Sex Hormones

    C. GnRH, FSH & LH & Sex Hormones

    ユーザ名非公開 · 45問 · 1年前

    C. GnRH, FSH & LH & Sex Hormones

    C. GnRH, FSH & LH & Sex Hormones

    45問 • 1年前
    ユーザ名非公開

    D. Thyroid Hormones

    D. Thyroid Hormones

    ユーザ名非公開 · 15問 · 1年前

    D. Thyroid Hormones

    D. Thyroid Hormones

    15問 • 1年前
    ユーザ名非公開

    E. Diabetes Mellitus

    E. Diabetes Mellitus

    ユーザ名非公開 · 70問 · 1年前

    E. Diabetes Mellitus

    E. Diabetes Mellitus

    70問 • 1年前
    ユーザ名非公開

    F. Drugs for osteoporosis

    F. Drugs for osteoporosis

    ユーザ名非公開 · 21問 · 1年前

    F. Drugs for osteoporosis

    F. Drugs for osteoporosis

    21問 • 1年前
    ユーザ名非公開

    Rationale Quiz

    Rationale Quiz

    ユーザ名非公開 · 10問 · 1年前

    Rationale Quiz

    Rationale Quiz

    10問 • 1年前
    ユーザ名非公開

    A. Asthma

    A. Asthma

    ユーザ名非公開 · 34問 · 1年前

    A. Asthma

    A. Asthma

    34問 • 1年前
    ユーザ名非公開

    B. Allergic Rhinitis

    B. Allergic Rhinitis

    ユーザ名非公開 · 27問 · 1年前

    B. Allergic Rhinitis

    B. Allergic Rhinitis

    27問 • 1年前
    ユーザ名非公開

    問題一覧

  • 1

    Also known as presystemic metabolism

    First Pass Effect

  • 2

    High First Pass Effect: _____ Bioavailability

    Decreased

  • 3

    Must be swallowed and has COMPLETE first-pass effect

    Oral Route

  • 4

    Provides systemic effect

    Oral Route

  • 5

    Drug is inserted in the rectum

    Rectal Route

  • 6

    May give local or systemic effect Buccal route

    Rectal Route

  • 7

    Can partially bypass the first-pass effect

    Rectal Route

  • 8

    Placed BETWEEN gums and inner lining of the cheek

    Buccal Route

  • 9

    Placed under the tongue

    Sublingual route

  • 10

    Available dosage form for Nitroglycerin

    Sublingual route

  • 11

    ENTERAL routes that CAN COMPLETELY BYPASS FIRST PASS EFFECT

    Sublingual route, Buccal Route

  • 12

    Emergency route

    IV Push

  • 13

    Non Emergency Route (More that 30 minutes)

    IV Infusion

  • 14

    Both emergency and non emergency route (1-30 minutes)

    IV Bolus

  • 15

    Which is slower among the two

    Subcutaneous

  • 16

    Injected into the muscle

    Intramuscular

  • 17

    90 degrees angle

    Intramuscular

  • 18

    Injected into the veins

    Intravenous

  • 19

    25 degrees angle

    Intravenous

  • 20

    100% Bioavailability or Absolute availability

    Intravenous

  • 21

    TB testing route

    Intradermal

  • 22

    Allergy testing route

    Intradermal

  • 23

    Injected into the dermis

    Intradermal

  • 24

    Injected into the corium

    Intradermal

  • 25

    10-15 degree angle

    Intradermal

  • 26

    Carbonic Anhydrase Inhibitor that is DIURETIC also a treatment for GLAUCOMA

    Acetazolamide

  • 27

    Injected under the skin

    Subcutaneous

  • 28

    25 degrees angle

    Subcutaneous

  • 29

    Drug given via subcutaneous route

    Heparin

  • 30

    Drug given via subcutaneous route

    Insulin

  • 31

    Injected into the spinal canal

    Intrathecal

  • 32

    Injected into the subarachnoid spaces

    Intrathecal

  • 33

    20 degrees angle

    Intrathecal

  • 34

    Methotrexate

    Intrathecal

  • 35

    Cytarabine

    Intrathecal

  • 36

    Hydrocortisone

    Intrathecal

  • 37

    Morphine

    Intrathecal

  • 38

    Morphine

    Intrathecal

  • 39

    Vinca alkaloids such as Vincristine when given intrathecally:

    Fatal

  • 40

    Injected inside the joint cavity

    Intra-articular

  • 41

    45 degree angle

    Intra-articular

  • 42

    Route of Glucocorticoids for Osteoarthritis

    Intra-articular

  • 43

    Route of Hyarulonic acid for Osteoarthritis

    Intra-articular

  • 44

    Identify the ROA used in the graph This is given via IV

    IV Bolus

  • 45

    Identify the route of administration used in the graph Given via IV

    IV Infusion

  • 46

    Identify the route of administration used in the graph Given via orally

    Extended release

  • 47

    Identify the route of administration used in the graph Given via orally

    Immediate release

  • 48

    Quick release when taken orally

    Immediate release

  • 49

    Steady state drug concentration

    Extended release

  • 50

    Allows precise control of PLASMA drug concentration

    IV Infusion

  • 51

    Rapid injection of medication needed to achieve immediate effect

    IV Bolus

  • 52

    Peak concentration is obtained Immediately after the dose is given

    IV Bolus

  • 53

    What is collor green in the graph

    Extended released

  • 54

    What is collor red in the graph

    Immediate released

  • 55

    What is collor blue in the graph

    Delayed released

  • 56

    Drug A is extended release and Drug B is given delayed release but has the same brand

    Pharmaceutical Alternative

  • 57

    What ROA are the zigzags, red and black

    Multiple IV Bolus

  • 58

    What ROA is the curve line color black?

    IV Infusion

  • 59

    Cmax

    Peak

  • 60

    Cmin

    Trough

  • 61

    Time the trough level needed to reach the MEC

    8

  • 62

    Time the trough level needed to reach the CSS or Concentration of Steady State

    16

  • 63

    What would most likely be the reason for the drug’s increasing plasma concentration towards reaching the therapeutic range?

    Decreasing clearance of the drug thru time

  • 64

    Increasing Plasma Concentration = Increased half life = _______ Drug clearance

    Decreasing

  • 65

    Administered at the SITE where the pharmacological response is desired

    Local Route

  • 66

    Have MINIMAL absorption to the SYSTEMIC circulation

    Local Route

  • 67

    Salbutamol for Asthma

    Local Route

  • 68

    Topical steroids for Eczema

    Local Route

  • 69

    ICS drugs for Allrgic rhinitis

    Local Route

  • 70

    The drug administered reaches the blood stream and produce systemic effect

    Systemic Route

  • 71

    Oral Amoxicillin

    Systemic Effect

  • 72

    Intravenous and Intramuscular

    Systemic Effect

  • 73

    Transdermal patch

    Systemic Effect

  • 74

    Rectal

    Both

  • 75

    Bronchodilators

    Local effects

  • 76

    GENERAL anesthesia

    Systemic Effect

  • 77

    Which of the following refers to the form of parenteral administration that involves injecting drugs such as methotrexate to the spinal cord?

    Intrathecal

  • 78

    The peak concentration for an intravenous bolus dose would be obtained ____.

    Immediately after the dose is given

  • 79

    Which are TRUE regarding local effect of drugs? I. Drug is administered at the site where the pharmacological response is desired. II. Drug preparations intended to produce local effects have minimal absorption to the systemic circulation. III. Anti-asthma drugs administered via inhalational route produce local effects.

    I, II and III